Wikipedia -WSS

Wikipedia

author：explore 2025-09-14 18:30:01 - browse：552

President Joe Biden speaks and gestures at a podium outdoor — In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors. MANDEL NGAN/AFP via Getty Images

WASHINGTON — The Biden administration announced Tuesday that it’s raising taxes on a range of imported products from China, including syringes, needles, and surgical gloves.

Pitched as a plan to support American workers, the tariffs are meant to protect domestic manufacturers from China’s “unfair trade practices” and “artificially low-priced exports.” In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors.

Related: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

The inclusion of syringes comes after the Food and Drug Administration’s repeated warnings to U.S. medical providers about quality issues with plastic syringes from China. The agency first alerted consumers in November 2023 about leaks and breaks associated with Chinese syringes. In March, the FDA called attention to three warning letters it sent to firms in China for selling syringes that had not received FDA clearance. It has since sent a warning letter to Cardinal Health.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Long Covid research funding gets a major boost from NIH

hotspot

WSS

Congress must protect the remaining independent doctors

Mass General, Mayo Clinic look to monetize custom

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Too many hospitalized Covid

Prior authorization reform is both possible and imperative

focus

Wikipedia

Related: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Wikipedia

Medical leaders decry Supreme Court decision on affirmative action

Maisha Meds is a PBM, but don't call it that

Affirmative action in medical school literally saved lives

Bernie Sanders gets little from pharma CEOs on drug prices

Wildfire smoke exposes gaps in outdoor worker protections

Having children helps parents live longer, especially after age 80

Hepatitis C has a cure — but many Americans still lack access to it

Cardiologists urge adding sexual orientation, gender identity to health records

Heart attack and stroke risk calculators need revising

Medicare bonuses could stop drug shortages under Senate plan

knowledge

Printout prescription drug information shouldn’t go digital

Doctors on social media are being harassed and cyberbullied

Readout Newsletter: Amylyx, Aurinia, and IQVIA

There's an unseen cost to disruptive road

Artificial intelligence use in health care faces greater scrutiny in 2024

Ebola vaccine can save some who are already sick, per new study

hotspot

explore

explore

leisure time